Tectonic Therapeutic (TECX) Retained Earnings (2017 - 2026)
Tectonic Therapeutic (TECX) posted quarterly Retained Earnings of $474.2 million for Q4 2025, up 5268344.44% year-over-year from N/an in Q4 2024, and up 333.0% quarter-over-quarter from -$203.5 million in Q3 2025.
Analysis
Tectonic Therapeutic (TECX) Retained Earnings (2017 - 2026) Analysis & Trends
Tectonic Therapeutic (TECX) has reported Retained Earnings for 9 consecutive years, with $474.2 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Retained Earnings rose 5268344.44% year-over-year to $474.2 million; the TTM figure through Dec 2025 stood at $474.2 million (up 5268344.44% YoY), while the FY2025 annual figure was $474.2 million, up 5268344.44% from the prior year.
- Retained Earnings climbed to $474.2 million in Q4 2025 per TECX's latest filing, from -$203.5 million in the prior quarter.
- Across five years, Retained Earnings topped out at $474.2 million in Q4 2025 and bottomed at -$514.4 million in Q1 2023.
- Historically, Retained Earnings has averaged -$243.1 million across 5 years, with a median of -$339.0 million in 2021.
- On a YoY basis, Retained Earnings climbed as much as 5268344.44% in 2025 and fell as far as 264185.71% in 2025.
- Tectonic Therapeutic's Retained Earnings stood at -$383.5 million in 2021, then declined by 27.61% to -$489.4 million in 2022, then jumped by 101.22% to $6.0 million in 2023, then tumbled by 99.85% to $9000.0 in 2024, then jumped by 5268344.44% to $474.2 million in 2025.
- Business Quant data shows TECX's Retained Earnings at $474.2 million in Q4 2025, -$203.5 million in Q3 2025, and -$184.5 million in Q2 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 15.69 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 37.62 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 558.00 Mn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 5.10 Bn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | -4.00 Bn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 13.05 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | -6.33 Bn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 4.38 Bn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 6.57 Bn |
| 10 | Tectonic Therapeutic | 589.02 Mn | 589.02 Mn | - | 494.11 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 494.11 Mn |
| Mar 31, 2026 | 478.39 Mn |
| Dec 31, 2025 | 474.16 Mn |
| Sep 30, 2025 | 471.11 Mn |
| Jun 30, 2025 | 468.29 Mn |
| Mar 31, 2025 | 465.52 Mn |
| Dec 31, 2024 | 289.35 Mn |
| Sep 30, 2024 | 286.65 Mn |
| Jun 30, 2024 | 284.92 Mn |
| Mar 31, 2024 | -484.08 Mn |
| Dec 31, 2023 | -90.60 Mn |
| Sep 30, 2023 | -468.49 Mn |
| Jun 30, 2023 | -446.91 Mn |
| Mar 31, 2023 | -514.39 Mn |
| Dec 31, 2022 | -489.43 Mn |
| Sep 30, 2022 | -464.40 Mn |
| Jun 30, 2022 | -441.43 Mn |
| Mar 31, 2022 | -413.38 Mn |
| Dec 31, 2021 | -383.54 Mn |
| Sep 30, 2021 | -355.32 Mn |